OBJECTIVES: This study sought to examine the treatment of @entity1 with @entity2704 in a prospective sample of @entity1 referred to a tertiary center for @entity10 . BACKGROUND: Despite the wide diffusion of guidelines for @entity10 management in @entity1 , their application in general practice is far from optimal. METHODS: This prospective study analyzed previous @entity10 treatment by general practitioners in 151 consecutive @entity1 (F/M: 0.82; mean age 10.4 +/- 3.2 years) referred for @entity2704 to the Lille University Hospital Neuropediatric department between October 1, 2003, and November 30, 2005. The physician completed a questionnaire according to the parents' responses to questions about previous advice about life-style adjustments (diet, exercise, and sleep hygiene) and abortive and prophylactic treatment. Questions about abortive treatment covered ergot derivatives, @entity2703 , and 3 aspects of @entity5018 use-appropriate dose (ie, more than 7.5 mg/kg), recommendation to administer the drug early in attacks, and warnings about @entity734 . Under the topic of prophylactic treatment, we asked about information from general practitioners about preventive therapy and advice to keep a @entity10 diary. RESULTS: Fewer than 15% of @entity1 had received advice about life-style adjustments. Only 30.3% had received @entity5018 at a correct dose (more than 7.5 mg/kg); only 26.5% were told to use it early during the @entity10 ; and only 9.1% were warned about @entity734 . Ergot derivatives were prescribed to 4.6% of @entity1 and @entity2703 to 9.1%. Families of 17.9% reported that the general practitioners gave them information about prophylactic treatment. Only 8.0% were advised to keep a @entity10 diary. CONCLUSION: This study shows the need to increase the role and the involvement of family doctors in the management of primary @entity10 in @entity1 in general, and of pediatric @entity2704 in particular.

French general practitioners' management of XXXX 's @entity2704 .

@entity1 :: ('9606', 'Species') :: ['children', 'patients'] @entity2703 :: ('MESH:D014363', 'Chemical') :: ['triptans'] @entity5018 :: ('MESH:D007052', 'Chemical') :: ['ibuprofen'] @entity2704 :: ('MESH:D008881', 'Disease') :: ['migraine', 'migraine headaches', 'migraines'] @entity10 :: ('MESH:D006261', 'Disease') :: ['headache', 'headaches'] @entity734 :: ('MESH:D019966', 'Disease') :: ['drug abuse']
@entity1 :: (9606,Species) :: ['children']
